Skip to main content
. 2017 Oct 27;12(10):e0186715. doi: 10.1371/journal.pone.0186715

Fig 1. Flowchart of the study population.

Fig 1

ALD, alcoholic liver disease; HBV, hepatitis B virus; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; NAFLD, non-alcoholic fatty liver disease.